J
John R. Goellner
Researcher at Mayo Clinic
Publications - 119
Citations - 16105
John R. Goellner is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Thyroid & Carcinoma. The author has an hindex of 64, co-authored 119 publications receiving 15631 citations. Previous affiliations of John R. Goellner include University of Rochester.
Papers
More filters
Journal ArticleDOI
Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
TL;DR: A reliable prognostic scoring system for predicting PTC mortality rates with 15 candidate variables that included completeness of primary tumor resection but excluded histologic grade and DNA ploidy is attempted.
Journal ArticleDOI
Fine-Needle Aspiration Biopsy of the Thyroid: An Appraisal
Hossein Gharib,John R. Goellner +1 more
TL;DR: The utility and limitations of fine-needle aspiration biopsy in the evaluation and management of thyroid nodules are examined by reviewing studies reported in the literature from 1982 to 1991 and using 12 years of experience with more than 11 000 biopsies to offer a reasoned approach to the management of nodular thyroid disease.
Journal ArticleDOI
Management of thyroid nodules detected at US: Society of radiologists in ultrasound consensus conference statement
Mary C. Frates,Carol B. Benson,J. William Charboneau,Edmund S. Cibas,Orlo H. Clark,Beverly G. Coleman,John J. Cronan,Peter M. Doubilet,Douglas B. Evans,John R. Goellner,Ian D. Hay,Barbara S. Hertzberg,Charles M. Intenzo,R. Brooke Jeffrey,Jill E. Langer,P. Reed Larsen,Susan J. Mandel,William D. Middleton,Carl C. Reading,Steven I. Sherman,Franklin N. Tessler +20 more
TL;DR: The recommendations in this consensus statement, which are based on analysis of the current literature and common practice strategies, are thought to represent a reasonable approach to thyroid nodular disease.
Journal ArticleDOI
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
Ian D. Hay,Maeve E. Hutchinson,Tomas Gonzalez-Losada,Bryan McIver,Megan S. Reinalda,Clive S. Grant,Geoffrey B. Thompson,Thomas J. Sebo,John R. Goellner +8 more
TL;DR: More than 99% of papillary thyroid microcarcinoma patients are not at risk of distant spread or cancer mortality, and RRA after BLR did not improve postoperative outcome.
Journal ArticleDOI
Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.
Ian D. Hay,Geoffrey B. Thompson,Clive S. Grant,Eric J. Bergstralh,Catherine E. Dvorak,Colum A. Gorman,Megan S. Maurer,Bryan McIver,Brian P. Mullan,Ann L. Oberg,Claudia C. Powell,Jon A. van Heerden,John R. Goellner +12 more
TL;DR: It is uncertain whether more extensive primary surgery and increasing use of radioiodine remnant ablation for papillary thyroid carcinoma (PTC) have resulted in improved rates of cause-specific mortality (CSM) and tumor recurrence (TR).